Concentrix Analysts Slash Their Forecasts After Downbeat Q2 Results

Benzinga Earnings

06/30

Concentrix Corp (NASDAQ:CNXC) on Monday reported worse-than-expected second-quarter financial results and cut its FY26 guidance below estimates.

Concentrix reported quarterly earnings of $2.63 per share, which missed the analyst consensus estimate of $2.64, according to Benzinga Pro data. Quarterly revenue came in at $2.46 billion, which missed the consensus estimate of $2.47 billion by 0.44%.

"Our second quarter marked an acceleration in many areas in the evolution of our business," said Chris Caldwell, CEO of Concentrix.

Concentrix lowered its fiscal 2026 adjusted EPS guidance to between $10.83 and $11.18, versus the $11.97 analyst estimate, and lowered its revenue outlook to $9.93 billion to $10.03 billion, versus the $10.14 billion estimate.

Concentrix shares dipped 18.2% to trade at $20.64 on Tuesday.

These analysts made changes to their price targets on Concentrix following earnings announcement.

Baird analyst David Koning maintained the stock with an Outperform rating and lowered the price target from $40 to $30.
Barrington Research analyst Vincent Colicchio maintained the stock with an Outperform rating and lowered the price target from $38 to $30.

Considering buying CNXC stock? Here’s what analysts think:

Photo via Shutterstock

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/2647838557"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2647838557\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2647838557?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-30 22:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2647838557","market":"hk","top_or_hot":-1,"title":"Concentrix Analysts Slash Their Forecasts After Downbeat Q2 Results","media":"Benzinga Earnings","content":"<html><body><p><strong><a href=\"https://laohu8.com/S/CNXC\">Concentrix Corp</a> </strong>(NASDAQ:CNXC) on Monday reported worse-than-expected second-quarter financial results and cut its FY26 guidance below estimates.</p>\n<p>Concentrix reported quarterly earnings of $2.63 per share, which missed the analyst consensus estimate of $2.64, according to Benzinga Pro data. Quarterly revenue came in at $2.46 billion, which missed the consensus estimate of $2.47 billion by 0.44%.</p>\n<p>\"Our second quarter marked an acceleration in many areas in the evolution of our business,\" said Chris Caldwell, CEO of Concentrix.</p>\n<p>Concentrix lowered its fiscal 2026 adjusted EPS guidance to between $10.83 and $11.18, versus the $11.97 analyst estimate, and lowered its revenue outlook to $9.93 billion to $10.03 billion, versus the $10.14 billion estimate.</p>\n<p>Concentrix shares dipped 18.2% to trade at $20.64 on Tuesday.</p>\n<p>These analysts made changes to their price targets on Concentrix following earnings announcement.</p>\n<ul>\n<li>Baird analyst David Koning maintained the stock with an Outperform rating and lowered the price target from $40 to $30.</li>\n<li>Barrington Research analyst Vincent Colicchio maintained the stock with an Outperform rating and lowered the price target from $38 to $30.</li>\n</ul>\n<p><strong>Considering buying CNXC stock? Here’s what analysts think:</strong></p>\n<figure><img decoding=\"async\" height=\"483\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833-1024x483.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833-1024x483.png 1024w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833-300x141.png 300w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833-768x362.png 768w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833.png 1192w\" width=\"1024\"/></figure>\n<p><em>Photo via Shutterstock</em></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Concentrix Analysts Slash Their Forecasts After Downbeat Q2 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nConcentrix Analysts Slash Their Forecasts After Downbeat Q2 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga Earnings </p>\n<p class=\"h-time\">2026-06-30 22:45</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p><strong><a href=\"https://laohu8.com/S/CNXC\">Concentrix Corp</a> </strong>(NASDAQ:CNXC) on Monday reported worse-than-expected second-quarter financial results and cut its FY26 guidance below estimates.</p>\n<p>Concentrix reported quarterly earnings of $2.63 per share, which missed the analyst consensus estimate of $2.64, according to Benzinga Pro data. Quarterly revenue came in at $2.46 billion, which missed the consensus estimate of $2.47 billion by 0.44%.</p>\n<p>\"Our second quarter marked an acceleration in many areas in the evolution of our business,\" said Chris Caldwell, CEO of Concentrix.</p>\n<p>Concentrix lowered its fiscal 2026 adjusted EPS guidance to between $10.83 and $11.18, versus the $11.97 analyst estimate, and lowered its revenue outlook to $9.93 billion to $10.03 billion, versus the $10.14 billion estimate.</p>\n<p>Concentrix shares dipped 18.2% to trade at $20.64 on Tuesday.</p>\n<p>These analysts made changes to their price targets on Concentrix following earnings announcement.</p>\n<ul>\n<li>Baird analyst David Koning maintained the stock with an Outperform rating and lowered the price target from $40 to $30.</li>\n<li>Barrington Research analyst Vincent Colicchio maintained the stock with an Outperform rating and lowered the price target from $38 to $30.</li>\n</ul>\n<p><strong>Considering buying CNXC stock? Here’s what analysts think:</strong></p>\n<figure><img decoding=\"async\" height=\"483\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833-1024x483.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833-1024x483.png 1024w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833-300x141.png 300w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833-768x362.png 768w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833.png 1192w\" width=\"1024\"/></figure>\n<p><em>Photo via Shutterstock</em></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2065170008.USD","symbol_name":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) INC","start_time":0,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/06/60189980/concentrix-analysts-slash-their-forecasts-after-downbeat-q2-results","article_id":"2647838557","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2647838557","pubTimestamp":1782830756,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga Earnings","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":"Concentrix (CNXC) reports lower-than-expected Q2 earnings and cuts FY26 guidance. Analysts lower price targets. Stock falls 18.2% to $20.64.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2065170008.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) INC","BK4226":"数据处理及外包服务","LU2065171311.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) ACC","CNXC":"Concentrix Corp","LU2065169927.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) ACC","LU2065171402.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) INC","BK4106":"数据处理与外包服务"},"translate_title":"Concentrix分析师在第二季度业绩悲观后大幅下调预测","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CNXC":1},"content_text":"Concentrix Corp (NASDAQ:CNXC) on Monday reported worse-than-expected second-quarter financial results and cut its FY26 guidance below estimates.\nConcentrix reported quarterly earnings of $2.63 per share, which missed the analyst consensus estimate of $2.64, according to Benzinga Pro data. Quarterly revenue came in at $2.46 billion, which missed the consensus estimate of $2.47 billion by 0.44%.\n\"Our second quarter marked an acceleration in many areas in the evolution of our business,\" said Chris Caldwell, CEO of Concentrix.\nConcentrix lowered its fiscal 2026 adjusted EPS guidance to between $10.83 and $11.18, versus the $11.97 analyst estimate, and lowered its revenue outlook to $9.93 billion to $10.03 billion, versus the $10.14 billion estimate.\nConcentrix shares dipped 18.2% to trade at $20.64 on Tuesday.\nThese analysts made changes to their price targets on Concentrix following earnings announcement.\n\nBaird analyst David Koning maintained the stock with an Outperform rating and lowered the price target from $40 to $30.\nBarrington Research analyst Vincent Colicchio maintained the stock with an Outperform rating and lowered the price target from $38 to $30.\n\nConsidering buying CNXC stock? Here’s what analysts think:\n\nPhoto via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"express","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}